Bank of New York Mellon’s ClearPoint Neuro CLPT Stock Holding History

Bank of New York Mellon’s Portfolio CLPT Stock Details CLPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.71M	Buy	151,767 +8,020	+6%	+$100K	﹤0.01%	2773
2026 Q1	$1.31M	Buy	143,747 +40,741	+40%	+$514K	﹤0.01%	3052
2025 Q4	$1.41M	Sell	103,006 -1,144	-1%	-$21.2K	﹤0.01%	3047
2025 Q3	$2.27M	Buy	104,150 +5,189	+5%	+$61.1K	﹤0.01%	2731
2025 Q2	$1.18M	Buy	+98,961	New	+$1.25M	﹤0.01%	3041
2024 Q2	–	Sell	-55,689	Closed	-$379K	–	4151
2024 Q1	$379K	Sell	55,689 -6,328	-10%	-$44.2K	﹤0.01%	3680
2023 Q4	$421K	Sell	62,017 -1,019	-2%	-$5.77K	﹤0.01%	3648
2023 Q3	$316K	Buy	63,036 +1,932	+3%	+$11.5K	﹤0.01%	3780
2023 Q2	$442K	Buy	61,104 +50,442	+473%	+$429K	﹤0.01%	3670
2023 Q1	$90K	Hold	10,662	–	–	﹤0.01%	4092
2022 Q4	$90.3K	Sell	10,662 -10	-0.1%	-$95	﹤0.01%	4134
2022 Q3	$110K	Buy	+10,672	New	+$141K	﹤0.01%	4180
2022 Q2	–	Sell	-50,994	Closed	-$531K	–	4602
2022 Q1	$531K	Buy	50,994 +555	+1%	+$5.05K	﹤0.01%	3669
2021 Q4	$566K	Buy	50,439 +264	+0.5%	+$3.95K	﹤0.01%	3729
2021 Q3	$891K	Buy	50,175 +6,735	+16%	+$126K	﹤0.01%	3455
2021 Q2	$829K	Buy	+43,440	New	+$839K	﹤0.01%	3531
2021 Q1	–	Sell	-10,255	Closed	-$163K	–	4324
2020 Q4	$163K	Buy	+10,255	New	+$92K	﹤0.01%	4018

Other funds holding CLPT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Pier Capital Stamford, Connecticut $755M AUM 94.38% 1-Year Est. Return

PCM

Parsons Capital Management Providence, Rhode Island $2.21B AUM 28.12% 1-Year Est. Return

PHS

Pekin Hardy Strauss Chicago, Illinois $1.14B AUM 37.36% 1-Year Est. Return

TFCM

Taylor Frigon Capital Management Scottsdale, Arizona $214M AUM 47.29% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

CCM

Conway Capital Management Burbank, California $225M AUM 19.09% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Bank of New York Mellon's CLPT Position: Q2 2026 in Review

Bank of New York Mellon increased its ClearPoint Neuro (CLPT) stake by 5.6% in Q2 2026, buying an estimated $100K and bringing the position to 151,767 shares worth $2.71M. The position accounts for ﹤0.01% of the portfolio, ranked #2773.

Bank of New York Mellon first reported a position in CLPT in Q4 2020 and has held it in 17 quarters since. 49 funds tracked by Wall St. Rank hold CLPT as of Q2 2026.

Bank of New York Mellon held 151,767 shares of ClearPoint Neuro worth $2.71M as of Q2 2026.
Bank of New York Mellon bought 8,020 ClearPoint Neuro shares in Q2 2026, an estimated $100K.
ClearPoint Neuro made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #2773 holding.
Bank of New York Mellon first reported a position in ClearPoint Neuro in Q4 2020 and has held it in 17 quarters since.
49 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.